These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Changes in national insurance reimbursement with introduction of the DPC package payment system for 131I therapy for hyperthyroidism].
    Author: Watanabe S, Kosuda S, Yano F, Abe K, Kusano S, Tanaka Y.
    Journal: Kaku Igaku; 2004 Nov; 41(4):415-9. PubMed ID: 15690770.
    Abstract:
    The inpatient DPC package payment system lowers national insurance reimbursement as compared to the former fee-for-service payment system for inpatients, when an inpatient with hyperthyroidism or toxic multinodular goiter (TMNG) is admitted for 2-day radioiodine therapy. The differentials are 29,970 yen and 48,870 yen for a 2-day hospital stay for administration of 555 MBq and 925 MBq, respectively. We request the Health and Labor Ministry to newly establish the fee for 131I internal therapy for hyperthyroidism. Furthermore, the fee should be paid according to the fee-for-service payment system.
    [Abstract] [Full Text] [Related] [New Search]